Overview

A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain

Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
There is an urgent public health need to reduce reliance on opioids for effective long-term pain management, particularly in knee osteoarthritis (KOA). This effectiveness trial will compare commonly recommended treatments to reduce pain and functional limitations in KOA.These results will lead to improved patient selection for treatment and inform evidence based guidelines by offering well-tested, effective, non-surgical alternatives.
Phase:
Phase 3
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Treatments:
Duloxetine Hydrochloride